IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q4 2020 Holdings

Filed 2021-02-16 | 33 holdings | $63.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$38.5M720,50260.3%
Arvinas Inc(ARVN)COM04335A105$13.9M164,15021.8%
Collegium Pharmaceutical Inc(COLL)COM19459J104$8.4M421,38313.2%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$2.4M175,0003.8%
GW Pharmaceuticals PLCADS36197T103$45.0K390,0000.1%
Iovance Biotherapeutics Inc(IOVA)COM462260100$42.6K917,4270.1%
Sage Therapeutics Inc(SG7)COM78667J108$39.3K454,4170.1%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$38.4K700,0000.1%
Zymeworks IncCOM98985W102$37.8K799,7220.1%
Intersect ENT IncCOM46071F103$29.8K1,302,8710.0%
Constellation Pharmceticls I(CNST)COM210373106$29.5K1,024,8000.0%
Macrogenics Inc(MGNX)COM556099109$28.3K1,239,2870.0%
Vericel Corp(VCEL)COM92346J108$27.8K900,0000.0%
Arena Pharmaceuticals Inc(ARNAEUR)COM NEW040047607$26.5K345,1200.0%
Global Blood Therapeutics inCOM37890U108$25.8K595,4730.0%
United Therapeutics Corp del(UTHR)COM91307C102$22.8K150,0000.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$17.7K856,1620.0%
Kadmon Hldgs Inc(KDMN)COM48283N106$16.9K4,083,9090.0%
Insulet Corp(PODD)COM45784P101$15.3K60,0000.0%
Theravance Biopharma Inc(TBPH)COMG8807B106$14.7K824,5800.0%
Puma Biotechnology Inc(PBYI)COM74587V107$13.3K1,300,0000.0%
Mersana Therapeutics IncCOM59045L106$13.0K487,4520.0%
Prothena Corp PLC(PRTA)SHSG72800108$11.7K977,6470.0%
Exelixis Inc(EXEL)COM30161Q104$9.5K475,0000.0%
Calithera Biosciences Inc(CALAEUR)COM13089P101$9.1K1,845,0000.0%
Forma Therapeutics Hldgs IncSHS34633R104$8.3K236,4000.0%
Geron Corp(GERN)COM374163103$8.0K5,055,1890.0%
Fibrogen Inc(FGENEUR)CallCOM31572Q808$6.2K166,5000.0%
Pulmonx Corp(LUNG)COM745848101$4.4K64,3450.0%
Ionis Pharmaceuticals Inc(IONS)COM462222100$4.2K75,0000.0%
Silverback Therapeutics Inc(SPRY)COM82835W108$3.2K70,0000.0%
Calithera Biosciences Inc(CALAEUR)CallCOM13089P101$2.5K500,0000.0%
Millendo Therapeutics IncCOM60040X103$578270,0000.0%